Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?

Summary

Wall Street analysts have set a price target on Definium Therapeutics (DFTX) representing 34.86% upside potential from current levels. The article presents analyst sentiment but contains no material corporate developments or clinical data.